Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Non-Current Deffered Revenue (2017 - 2022)

Historic Non-Current Deffered Revenue for Q32 Bio (QTTB) over the last 6 years, with Q1 2022 value amounting to $354000.0.

  • Q32 Bio's Non-Current Deffered Revenue fell 9006.18% to $354000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $354000.0, marking a year-over-year decrease of 9006.18%. This contributed to the annual value of $1.2 million for FY2021, which is 9640.36% down from last year.
  • As of Q1 2022, Q32 Bio's Non-Current Deffered Revenue stood at $354000.0, which was down 9006.18% from $1.2 million recorded in Q4 2021.
  • Q32 Bio's 5-year Non-Current Deffered Revenue high stood at $32.1 million for Q4 2020, and its period low was $354000.0 during Q1 2022.
  • For the 5-year period, Q32 Bio's Non-Current Deffered Revenue averaged around $21.8 million, with its median value being $29.8 million (2020).
  • As far as peak fluctuations go, Q32 Bio's Non-Current Deffered Revenue skyrocketed by 663.86% in 2020, and later crashed by 9640.36% in 2021.
  • Over the past 5 years, Q32 Bio's Non-Current Deffered Revenue (Quarter) stood at $30.8 million in 2018, then decreased by 1.98% to $30.1 million in 2019, then grew by 6.64% to $32.1 million in 2020, then crashed by 96.4% to $1.2 million in 2021, then plummeted by 69.38% to $354000.0 in 2022.
  • Its last three reported values are $354000.0 in Q1 2022, $1.2 million for Q4 2021, and $2.0 million during Q3 2021.